These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 38911503)

  • 1. Mitigation of Oxidative Stress in Idiopathic Pulmonary Fibrosis Through Exosome-Mediated Therapies.
    Wang Z; Zhang Y; Li X
    Int J Nanomedicine; 2024; 19():6161-6176. PubMed ID: 38911503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress, extracellular matrix targets, and idiopathic pulmonary fibrosis.
    Kliment CR; Oury TD
    Free Radic Biol Med; 2010 Sep; 49(5):707-17. PubMed ID: 20452419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The disturbed redox-balance in pulmonary fibrosis is modulated by the plant flavonoid quercetin.
    Veith C; Drent M; Bast A; van Schooten FJ; Boots AW
    Toxicol Appl Pharmacol; 2017 Dec; 336():40-48. PubMed ID: 28987380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of oxidative stress biomarkers in idiopathic pulmonary fibrosis and therapeutic applications: a systematic review.
    Fois AG; Paliogiannis P; Sotgia S; Mangoni AA; Zinellu E; Pirina P; Carru C; Zinellu A
    Respir Res; 2018 Mar; 19(1):51. PubMed ID: 29587761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidant/Antioxidant Disequilibrium in Idiopathic Pulmonary Fibrosis Pathogenesis.
    Cameli P; Carleo A; Bergantini L; Landi C; Prasse A; Bargagli E
    Inflammation; 2020 Feb; 43(1):1-7. PubMed ID: 31297749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin induced oxidative stress attenuation by N-acetylcysteine co-treatment: a fibroblast and epithelial cell in-vitro study in idiopathic pulmonary fibrosis.
    Rodriguez LR; Bui SN; Beuschel RT; Ellis E; Liberti EM; Chhina MK; Cannon B; Lemma M; Nathan SD; Grant GM
    Mol Med; 2019 Jun; 25(1):27. PubMed ID: 31195971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative/nitrosative stress, autophagy and apoptosis as therapeutic targets of melatonin in idiopathic pulmonary fibrosis.
    Hosseinzadeh A; Javad-Moosavi SA; Reiter RJ; Yarahmadi R; Ghaznavi H; Mehrzadi S
    Expert Opin Ther Targets; 2018 Dec; 22(12):1049-1061. PubMed ID: 30445883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sputum exosomes: promising biomarkers for idiopathic pulmonary fibrosis.
    Njock MS; Guiot J; Henket MA; Nivelles O; Thiry M; Dequiedt F; Corhay JL; Louis RE; Struman I
    Thorax; 2019 Mar; 74(3):309-312. PubMed ID: 30244194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Traditional Chinese medicine inspired dual-drugs loaded inhalable nano-therapeutics alleviated idiopathic pulmonary fibrosis by targeting early inflammation and late fibrosis.
    Zheng M; Liu K; Li L; Feng C; Wu G
    J Nanobiotechnology; 2024 Jan; 22(1):14. PubMed ID: 38166847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nintedanib Ameliorates Bleomycin-Induced Pulmonary Fibrosis, Inflammation, Apoptosis, and Oxidative Stress by Modulating PI3K/Akt/mTOR Pathway in Mice.
    Pan L; Cheng Y; Yang W; Wu X; Zhu H; Hu M; Zhang Y; Zhang M
    Inflammation; 2023 Aug; 46(4):1531-1542. PubMed ID: 37160579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling the interplay between vital organelle stress and oxidative stress in idiopathic pulmonary fibrosis.
    Mohanan A; Washimkar KR; Mugale MN
    Biochim Biophys Acta Mol Cell Res; 2024 Mar; 1871(3):119676. PubMed ID: 38242330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of antioxidants in the treatment of gastroesophageal reflux disease-associated idiopathic pulmonary fibrosis.
    Nelkine L; Vrolijk MF; Drent M; Bast A
    Curr Opin Pulm Med; 2020 Jul; 26(4):363-371. PubMed ID: 32452901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CoQ10 enhances the efficacy of airway basal stem cell transplantation on bleomycin-induced idiopathic pulmonary fibrosis in mice.
    Liu H; Liu S; Jiang J; Zhang Y; Luo Y; Zhao J; Xu J; Xie Y; Liao W; Wang W; Nie Y; Li S; Deng W
    Respir Res; 2022 Feb; 23(1):39. PubMed ID: 35219329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress and antioxidants in the pathogenesis of pulmonary fibrosis: a potential role for Nrf2.
    Walters DM; Cho HY; Kleeberger SR
    Antioxid Redox Signal; 2008 Feb; 10(2):321-32. PubMed ID: 17999635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage-derived exosomes attenuate fibrosis in airway epithelial cells through delivery of antifibrotic miR-142-3p.
    Guiot J; Cambier M; Boeckx A; Henket M; Nivelles O; Gester F; Louis E; Malaise M; Dequiedt F; Louis R; Struman I; Njock MS
    Thorax; 2020 Oct; 75(10):870-881. PubMed ID: 32759383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis.
    Bocchino M; Agnese S; Fagone E; Svegliati S; Grieco D; Vancheri C; Gabrielli A; Sanduzzi A; Avvedimento EV
    PLoS One; 2010 Nov; 5(11):e14003. PubMed ID: 21103368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SLC15A3 plays a crucial role in pulmonary fibrosis by regulating macrophage oxidative stress.
    Luo J; Li P; Dong M; Zhang Y; Lu S; Chen M; Zhou H; Lin N; Jiang H; Wang Y
    Cell Death Differ; 2024 Apr; 31(4):417-430. PubMed ID: 38374230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liproxstatin-1 alleviates bleomycin-induced alveolar epithelial cells injury and mice pulmonary fibrosis via attenuating inflammation, reshaping redox equilibrium, and suppressing ROS/p53/α-SMA pathway.
    Tao N; Li K; Liu J; Fan G; Sun T
    Biochem Biophys Res Commun; 2021 Apr; 551():133-139. PubMed ID: 33735625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective Effects of Extracellular Matrix-Derived Hydrogels in Idiopathic Pulmonary Fibrosis.
    Evangelista-Leite D; Carreira ACO; Gilpin SE; Miglino MA
    Tissue Eng Part B Rev; 2022 Jun; 28(3):517-530. PubMed ID: 33899554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the lung microbiome as a therapeutic target in the management of idiopathic pulmonary fibrosis: role of antioxidant/antibiotic combination therapy.
    Varone F; Gibiino G; Gasbarrini A; Richeldi L
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6379-6386. PubMed ID: 31364146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.